Christophe Bancel
VENTURE PARTNER @ iBionext
Paris, France
Christophe Bancel is a startup investor at iBionext in Paris. Christophe Bancel is based out of Paris, Ile-de-France and is the Chief Executive Officer and Director at TISSIUM. Most recently, Christophe was Franchise General Manager at UCB, leading the Central Nervous System Operations in France. Prior to that, he held several corporate and strategic positions at UCB, including Pricing and Markets Access inthe US (Atlanta, GA), Global Marketing (Brussels) and Patient & Market Insight (Brussels). He also worked for Serono in multiple Sales and Marketing positions. He started his career in Biotech, as Business Developer at Transgene and then was a co-founder and Director of Corporate & Business Development at Faust Pharmaceuticals (now Domain Therapeutics). Christophe is a graduate from Ecole Centrale Paris (Master of Engineering), holds a Master in Biochemistry and Molecular Biology from the University of Tokyo (Todaï) and an MBA from INSEAD.Since 2012, he is a member of the iBionext Network.
Last updated:
For AI agents: llms.txt
About iBionext
iBionext is a unique healthcare fund created within a proven breakthrough innovation accelerator. Their companies are based in a single location named “Passage de l’innovation” in Paris, France. Over the past 4 years, we have created 7 companies that have raised over 250M € and created 103 highly qualified jobs.
iBionext Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alexia Perouse
Co-Founder & CEO
|
|||
Bernard Gilly
Founder & Chairman
|
|||
|
Christophe Bancel
VENTURE PARTNER
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
